artesunic acid has been researched along with B Virus Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertzbach, LD; Conradie, AM; Hahn, F; Kaufer, BB; Marschall, M; Wild, M | 1 |
| Auerochs, S; Bruggeman, CA; Efferth, T; Kalmer, M; Kaptein, SJ; Leis, M; Marschall, M; Rechter, S; Stamminger, T; Vink, C | 1 |
2 other study(ies) available for artesunic acid and B Virus Infection
| Article | Year |
|---|---|
Artesunate derivative TF27 inhibits replication and pathogenesis of an oncogenic avian alphaherpesvirus.
Topics: Alphaherpesvirinae; Animals; Antiviral Agents; Artesunate; Cell Transformation, Viral; Herpesviridae Infections; Incidence; Neoplasms; Poultry Diseases; Virus Replication | 2019 |
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
Topics: Animals; Antimalarials; Antiviral Agents; Artemisinins; Artesunate; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Ferrous Compounds; Fibroblasts; Herpesviridae Infections; Humans; Immunocompromised Host; Male; Muromegalovirus; Rats; Rats, Inbred Lew; Sesquiterpenes; Specific Pathogen-Free Organisms; Transferrin; Virus Replication | 2006 |